Pfizer’s Centers for Therapeutic Innovation (CTI) is now accepting pre-proposals for its 2021 CTI Call for Proposals.
CTI collaborates with academic institutions and investigators to push forward great science, using the depth and breadth of the Pfizer enterprise to accelerate concepts into viable therapies with breakthrough potential for patients.
Who can apply?
Weill researchers. Please contact Lisa Placanica, Senior Managing Director, CTL at WCM
Application Period Opens: March 22, 2021
Submission Deadline: June 28th 2021
Learn more about Pfizer’s areas of interest: https://www.pfizercti.com/?cmp=21flyer#interest